Digclav 375 Amoxycillin Potassium Clavulanate Tablets

Name: Digclav 375 Amoxycillin Potassium Clavulanate Tablets
Brand: Dignity Healthcare Pvt Ltd
Price: 178 INR
Availability: InStock

Price 178 INR/ Strip

Get a Price/Quote

MOQ : 100 Strips

Digclav 375 Amoxycillin Potassium Clavulanate Tablets Specification

Salt Composition
Amoxycillin 250 mg, Clavulanic Acid 125 mg

Pacakaging (Quantity Per Box)
60 Tablets

Dosage Form
Tablet

Indication
Respiratory tract, urinary, and skin infections

Origin of Medicine
India

Life Span
24 Months

Packaging Type
Box

Drug Type
Allopathic

Ingredients
Amoxycillin & Potassium Clavulanate

Physical Form
Tablets

Function
Antibiotic

Recommended For
Bacterial infections

Dosage
As prescribed by physician

Dosage Guidelines
Follow physicians instructions

Suitable For
Adults and children

Quantity
10 x 6 Tablets

Storage Instructions
Store in a cool, dry place

Tablet color
White

Active ingredient ratio
250:125 mg

IP standard
Yes

Prescription
Rx only

Strength
375 mg

Form
Oral tablet

Digclav 375 Amoxycillin Potassium Clavulanate Tablets Trade Information

Minimum Order Quantity
100 Strips

Supply Ability
5000 Strips Per Month

Delivery Time
2-5 Days

About Digclav 375 Amoxycillin Potassium Clavulanate Tablets

Reserve your supply of DIGCLAV-375 Amoxycillin Potassium Clavulanate Tablets today to enjoy a truly exceptional remedy against bacterial infections. Each tablet delivers a heroic combination of 250 mg Amoxycillin and 125 mg Potassium Clavulanate, perfectly suited for adults and children. Whether you need to conquer respiratory, urinary, or skin infections, these brilliant oral tablets uphold IP standards and guarantee both strength and safety. Pick yours now for a bargain in effective antibiotic protection. Packaged in convenient boxes of 60 tablets, DIGCLAV-375 is a trusted Rx-only solution from India for allopathic care.

Competitive Edge and Commercial Scope of DIGCLAV-375 Tablets

DIGCLAV-375 Tablets stand out due to their superior blend of active ingredients, adhering strictly to IP standards. Their competitive advantage lies in reliable efficacy against a broad spectrum of bacterial infections. Commercial users, including hospitals, clinics, and pharmaceutical traders, benefit from the convenient 10x6 packaging. Suitable for varied demographics, DIGCLAV-375 offers robust support in both acute and chronic infection management scenarios, making it a preferred product for professionals prioritizing patient outcomes and supply confidence.

Certifications, Samples, and Global Market Presence

DIGCLAV-375 Tablets command significant market value as a leading antibiotic with IP certification, enhancing credibility. Exporters and suppliers operate with streamlined logistics, offering sample availability for evaluation before large orders. The asking price reflects outstanding quality and regulatory compliance, making the tablets highly attractive across main export markets, such as Asia, Africa, and the Middle East. Commercial volumes are supported by rigorous certifications, ensuring that businesses can reliably source and distribute with assured standards and consistency.

FAQ's of Digclav 375 Amoxycillin Potassium Clavulanate Tablets:

Q: How should Digclav 375 Tablets be administered for optimal results?

A: Digclav 375 Tablets should be taken orally, strictly following your physician's prescribed dosage and instructions to ensure safe and effective treatment of bacterial infections.

Q: What infections are best treated with Digclav 375 Amoxycillin Potassium Clavulanate Tablets?

A: These tablets are recommended for managing respiratory tract, urinary, and skin infections caused by susceptible bacteria, providing a broad spectrum of antibacterial protection.

Q: When is it advisable to use Digclav 375 instead of other antibiotics?

A: Digclav 375 is particularly beneficial when combined therapy is indicated due to potential resistance to amoxycillin alone, or when the infection is unresponsive to standard antibiotics.

Q: Where are DIGCLAV-375 Tablets manufactured and what quality standards do they meet?

A: DIGCLAV-375 is manufactured in India and strictly adheres to IP (Indian Pharmacopoeia) standards, ensuring premium quality and reliable pharmaceutical formulation.

Q: What is the process for obtaining samples or bulk orders for export?

A: Interested traders or healthcare establishments can request product samples for evaluation. For bulk procurement, official orders can be placed with the exporter, ensuring seamless logistics and reliable supply channels.

Q: What are the main benefits of choosing Digclav 375 Tablets for commercial use?

A: DIGCLAV-375 offers consistent therapeutic efficacy, robust market value, and IP-standard quality, all supported by convenient packaging for commercial distribution and usage.

Tell us about your requirement